Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
Open Access
- 11 October 2024
- journal article
- research article
- Published by Wiley in BJUI Compass
- Vol. 5 (11) , 1173-1182
Abstract
Background: When faced with treatment options, patients are asked to participate in decision‐making. We sought to determine which treatment aspects matter most for individuals treated for muscle invasive bladder cancer (MIBC), with an aim to improve understanding of patient preferences and what trade‐offs patients are willing to accept. Our study consisted of a discrete choice experiment (DCE): a type of questionnaire used to elicit preferences in the absence of real‐world choice.Methods: The DCE had five attributives, each with three levels. Participants were asked to complete a questionnaire in which they were asked to choose between two hypothetical MIBC treatments. The data were analysed using a conditional logit model, and preferences for, and trade‐offs between, attributes were estimated.Results: We recruited patients with MIBC who had either already completed, were undergoing or had yet to commence radical treatment for MIBC (n = 60). Participants indicated a strong preference for treatments that increased their life expectancy (p = p = p = p = 0.09) or an increase in acute side effects (p = 0.99) did not influence preferences. Patients were willing to accept treatments with higher risk of long‐term complications to improve their life expectancy or body image.Conclusion: When deciding on the type of treatment, increased life expectancy is the most important consideration for people with MIBC. The risk of long‐term complications and changes to overall body image as a result of treatment are also important. Our study also highlighted that patients are willing to accept a higher risk of long‐term complications to improve other treatment outcomes. Understanding patient preferences is important for shared decision‐making, which has an impact on quality of care for people living with MIBC.Keywords
This publication has 21 references indexed in Scilit:
- A Longitudinal Evaluation of the Preferences of Patients With Advanced Cancer for Quality of Life and Survival in Malaysia: A Discrete Choice ExperimentValue in Health, 2023
- Partial and radical cystectomy provides equivalent oncologic outcomes in bladder cancer when combined with adequate lymph node dissection: A population-based studyUrologic Oncology: Seminars and Original Investigations, 2023
- P54 Patient Preferences for Treatment of BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: A Discrete Choice ExperimentValue in Health, 2022
- A Systematic Review of Discrete Choice Experiments in Oncology TreatmentsThe Patient - Patient-Centered Outcomes Research, 2021
- How well do discrete choice experiments predict health choices? A systematic review and meta-analysis of external validityThe European Journal of Health Economics, 2018
- Patients’ Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice ExperimentClinical Therapeutics, 2017
- Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder CancerEuropean Urology, 2017
- Patients’ Preferences for Surgical Management of Esophageal Cancer: A Discrete Choice ExperimentWorld Journal of Surgery, 2015
- Decision making and cancer.American Psychologist, 2015
- Discrete choice experiments in health economics: a review of the literatureHealth Economics, 2010